Delivery Order SPE2DB22D2206-SPE2DB24FHM96
Award Date 5/30/24
Potential Completion Date 5/31/24
Potential Value $1.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,318.56, was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. This contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $19,230.15. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 27, 2024. This contract is part of a larger Indefinite...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 30S to the Defense Logistics Agency (DLA). The $1,425.51 firm fixed price delivery order has an ultimate completion date of February 5, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA). The $11,323.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 25, 2024 with a completion date of July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $1,888.09. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $54,376.61 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $11,404.80, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 17, 2025, with a completion date of January 21, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,671.67 and a completion date of July 8, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and was awarded on July 5, 2024. No set-aside designation was used for this...
- This federal contract award is for the supply of GEMTESA 75 MG TABLET 90S pharmaceutical product to the U.S. Department of Defense's Medical Supply Chain. The $11,176.13 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical and medical products to federal agencies. The contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $15,734.82 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...